Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001214659-26-001502·Aligos Therapeutics, Inc.
Schedule 13G ownership disclosure
Aligos Therapeutics Inc
Common Stock, par value, $0.0001 per share · CUSIP: 01626L204
Event date: 2025-12-31
- Filing-level shares
- 335,937.00
- Percent of class
- 5.46%
- Sio Capital Management, LLC
Shares: 335,937.00 · Class: 5.46%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-26-001502
- Form type
- SCHEDULE 13G/A
- Filer
- Aligos Therapeutics, Inc.
- CIK
- CIK 1799448
- Filed
- Feb 11, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership